Narrative review / 2014
Hibiscus sabdariffa extracts show antioxidant, anti-hypertensive, and metabolic effects, but well-designed trials with characterized preparations are needed.
This review evaluates the phytochemical and pharmacological evidence for Hibiscus sabdariffa L. (Hs, roselle). In vitro and in vivo studies, along with some clinical trials, show antibacterial, antioxidant, nephro- and hepato-protective, diuretic, lipid-lowering, anti-diabetic, and anti-hypertensive effects. Proposed mechanisms include antioxidant actions, enzyme inhibition (α-glucosidase, α-amylase, ACE), and vaso-relaxant effects, likely driven by phenolic acids, organic acids, and anthocyanins. The authors note an excellent safety and tolerability record, but emphasize that most evidence is based on poorly characterized extracts and more well-designed controlled clinical trials using characterized preparations are needed.
- Study type
- Phytochemical and pharmacological review
- Who was studied
- In vitro, in vivo, and clinical trial subjects
- What was measured
- Pharmacological effects including antibacterial, antioxidant, lipid metabolism, anti-diabetic, and anti-hypertensive outcomes
THE PAPER
Hibiscus sabdariffa L. - a phytochemical and pharmacological review.
Da-Costa-Rocha I, Bonnlaender B, Sievers H, Pischel I, Heinrich M. Food Chem, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.